Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
NEW YORK and LONDON, Sept. 07, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ:…
HiBob Named Best HR Management Software in the UK for 2026
Ionik Announces 30-Day Extension of Senior Debt Facility
NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow
Voghion Expands Beyond Fashion to Build a One-Stop Lifestyle Platform Across Europe